Detalhe da pesquisa
1.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384759
2.
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol
; 96(15): e0055822, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867572
3.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
J Infect Dis
; 226(3): 510-520, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134995
4.
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.
PLoS Pathog
; 15(12): e1008064, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841557
5.
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
PLoS Med
; 17(5): e1003117, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442195
6.
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
PLoS Med
; 17(2): e1003038, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32092060
7.
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
PLoS Pathog
; 14(4): e1006987, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29630668
8.
Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.
Infect Immun
; 86(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038128
9.
Prospects for passive immunity to prevent HIV infection.
PLoS Med
; 14(11): e1002436, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136030
10.
Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.
J Virol
; 90(22): 10220-10235, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581986
11.
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4ß7 for replication.
Retrovirology
; 12: 54, 2015 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105197
12.
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
Sex Transm Infect
; 90(8): 580-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25107710
13.
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial.
Lancet HIV
; 10(4): e230-e243, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001964
14.
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
NPJ Vaccines
; 8(1): 119, 2023 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573434
15.
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Nat Commun
; 14(1): 8299, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097552
16.
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.
Hum Vaccin Immunother
; 18(1): 1908030, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213402
17.
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
Nat Med
; 28(9): 1924-1932, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995954
18.
Evaluation of CD103 (αEß7) integrin expression by CD8 T cells in blood as a surrogate marker to predict cervical T cell responses in the female genital tract during HIV infection.
Clin Immunol
; 141(2): 143-51, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21778119
19.
Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy.
J Virol
; 84(20): 10765-72, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20686039
20.
Initiation of Antiretroviral Therapy Differentially Influences Genital and Systemic Immune Activation in HIV-Infected Women.
AIDS Res Hum Retroviruses
; 36(10): 821-830, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524856